EGFR is a receptor tyrosine kinase that promotes the proliferation and invasion of breast cancer by stimulating multiple oncogenic pathways such as Ras-Raf-MEK-ERK, PI3K-AKT-mTOR, and Src-STAT3 (Wee and Wang, 2017). This evidence concerns the gene STAT3 and breast carcinoma.